NCT05185947
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer treatment 2 recruiting NCT05617755
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients with Platinum Resistant Epithelial Ovarian Cancer No drug interventions treatment 1 active_not_recruiting NCT00262990
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer treatment 3 completed NCT01462890
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer treatment 3 completed NCT00517621
Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire treatment 2 completed NCT00698451
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers treatment 2 completed NCT00502177
Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin No drug interventions Not Available Not Available completed NCT00103545
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response prevention 1 / 2 completed NCT00382811
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer treatment 3 completed NCT01478685
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 completed NCT00288275
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer No drug interventions Not Available Not Available terminated NCT06351475
Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy No drug interventions treatment Not Available not_yet_recruiting NCT03287375
Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy - treatment 2 completed NCT00318370
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy treatment 2 completed NCT03976999
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers No drug interventions other Not Available recruiting NCT00445549
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 terminated NCT00516841
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer treatment 2 terminated NCT02786524
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy No drug interventions supportive_care Not Available completed NCT00443196
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas No drug interventions treatment 2 / 3 completed NCT02082886
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry No drug interventions Not Available Not Available completed NCT01932125
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 4 active_not_recruiting NCT00436657
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer treatment 1 completed NCT00666991
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers treatment 1 completed NCT03150992
EDMONd - Elemental Diet in Bowel Obstruction No drug interventions supportive_care Not Available unknown_status NCT00074867
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer treatment 2 completed NCT00317772
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 completed NCT05194072
A Study of SGN-B7H4V in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01681368
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer treatment 2 terminated NCT00191646
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy treatment 3 completed NCT02658214
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors treatment 1 completed NCT05257408
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer treatment 3 active_not_recruiting NCT03246321
PIPAC for Peritoneal Metastases of Colorectal Cancer No drug interventions treatment 2 completed NCT02638051
Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT No drug interventions treatment 2 completed NCT02758951
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases treatment 2 / 3 active_not_recruiting NCT01384253
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy treatment 1 completed NCT00189345
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients treatment 2 completed NCT01314105
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer treatment 1 completed NCT01846611
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 3 completed NCT02903771
Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. treatment 1 completed NCT04111978
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) treatment 3 recruiting NCT01697488
An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) No drug interventions Not Available Not Available completed NCT02578888
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies No drug interventions supportive_care Not Available completed NCT00191607
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. treatment 3 completed NCT00407407
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma treatment 1 terminated NCT00001332
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis No drug interventions treatment 1 completed NCT03038100
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT00035100
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer treatment 2 completed NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer treatment 3 completed NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery treatment 3 active_not_recruiting NCT00332696
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis treatment 2 completed NCT06223763
SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery No drug interventions Not Available Not Available recruiting NCT02231086
Adjuvant HIPEC in High Risk Colon Cancer prevention 3 completed NCT00112086
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 treatment 2 completed NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer treatment 1 / 2 active_not_recruiting NCT01225757
Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC No drug interventions diagnostic Not Available withdrawn NCT03740165
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) treatment 3 active_not_recruiting NCT05353582
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases No drug interventions treatment 2 not_yet_recruiting NCT02478476
DNA Single Nucleotide Polymorphisms as Predictors of Toxicity No drug interventions Not Available Not Available unknown_status NCT00183794
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma treatment 2 completed NCT00086567
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers No drug interventions Not Available Not Available completed NCT00063401
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer treatment 2 completed NCT00216372
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis treatment 3 completed NCT03593681
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy No drug interventions Not Available Not Available completed NCT00352755
A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis treatment 2 terminated NCT00006155
SU5416 and Carboplatin to Treat Ovarian Cancer treatment 1 completed NCT00004547
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy treatment 2 completed NCT00391118
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") treatment 2 completed NCT00001569
Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis treatment 1 completed